Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON

Disc Medicine

Disc Medicine clinical programs — 308 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
442
Patents
706
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Disc Medicine projects

308 ClinicalTrials.gov programs sponsored by Disc Medicine.

Disc Medicine has 308 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

308 programs

Clinical programs

Page 5 of 7

  1. NL66938.041.19

    Disc Medicine

    colorectal liver metastases

    phase 1 other active

    1 trial

  2. NL85300.041.23

    Disc Medicine

    Metastatic or unresectable solid malignancies. Standard of care treatment options must not be available or not be considered feasible. Patients must have a primary tumor or metastasis that is suitable for HIFU-HT treatment.

    phase 1 other active

    1 trial

  3. Optical PD-L1 imaging using Quantitative Fluo... for Esophageal cancer

    Disc Medicine

    Esophageal cancer

    phase 1 other active

    1 trial

  4. Oxytocine and migraine

    Disc Medicine

    This is a study in healthy volunteers. We will study the trigeminovascular system, which is relevant in the pathophysiology of migraine.

    phase 1 other active

    1 trial

  5. Panama ID: 8070

    Disc Medicine

    peritoneal metastases of colorectal origin

    phase 1 other active

    1 trial

  6. Phase 0 trial of CBD in recurrent glioblastoma patients

    Disc Medicine

    Glioblastoma

    phase 1 other active

    1 trial

  7. Phase I study of 225Ac-PSMA I&T in prostate cancer

    Disc Medicine

    metastatic prostate cancer

    phase 1 other active

    1 trial

  8. RESTART; Autologous Transplantation of Adult...

    Disc Medicine

    Patients operated with curative intend for head and neck cancer with an indication for bilateral postoperative radiotherapy, with or without chemotherapy.

    phase 1 other active

    1 trial

  9. STRATIFY; Near-infrared fluorescence molecula...

    Disc Medicine

    Crohn's disease, Spondyloarthritis, Rheumatoid arthritis, Ulcerative colitis

    phase 1 other active

    1 trial

  10. Safety of TEG001 in patients with r/r AML/high-risk MDS or r/r MM

    Disc Medicine

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma (MM)

    phase 1 other active

    1 trial

  11. TIL in NSCLC

    Disc Medicine

    Respiratory tract diseases

    phase 1 other active

    1 trial

  12. UMCG-NEOLYNC-001

    Disc Medicine

    Cervical Cancer

    phase 1 other active

    1 trial

  13. 103900

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  14. 112771

    Disc Medicine

    Fungal infection

    approved small molecule active

    1 trial

  15. 114180

    Disc Medicine

    Stroke

    approved small molecule active

    1 trial

  16. 115083

    Disc Medicine

    Dystonic tremor syndrome

    approved small molecule active

    1 trial

  17. 116795

    Disc Medicine

    Type 1 Diabetes

    approved small molecule active

    1 trial

  18. 18253

    Disc Medicine

    Albuminuria, Type 2 diabetes

    approved small molecule active

    1 trial

  19. 19-659

    Disc Medicine

    Carotid artery stenosis

    approved small molecule active

    1 trial

  20. 202000842

    Disc Medicine

    Depression

    approved small molecule active

    1 trial

  21. 2024-515363-63-00

    Disc Medicine

    Asplenia

    approved small molecule active

    1 trial

  22. 2024-517043-32-00

    Disc Medicine

    Post Transplantation Patients

    approved small molecule active

    1 trial

  23. 2024-517112-30-00

    Disc Medicine

    Rheumatoid arthritis

    approved small molecule active

    1 trial

  24. 20725

    Disc Medicine

    Chronic Kidney disease

    approved small molecule active

    1 trial

  25. 22-571/21U-0151

    Disc Medicine

    Congenital Haemophilia A

    approved small molecule active

    1 trial

  26. 22590

    Disc Medicine

    Metastatic cervical cancer

    approved small molecule active

    1 trial

  27. 54659

    Disc Medicine

    Hand eczema

    approved small molecule active

    1 trial

  28. ACETYLSALICYLIC ACID for Peripheral Arterial Disease

    Disc Medicine

    Peripheral Arterial Disease

    approved small molecule active

    1 trial

  29. ADALIMUMAB , INFLIXIMAB

    Disc Medicine

    Crohn's disease Ulcerative colitis

    approved small molecule active

    1 trial

  30. AMINOHIPPURIC ACID for Chronic Kidney Disease Kidney Failure

    Disc Medicine

    Chronic Kidney Disease Kidney Failure

    approved small molecule active

    1 trial

  31. ARIPIPRAZOLE , RISPERIDONE

    Disc Medicine

    Autism spectrum disorder

    approved small molecule active

    1 trial

  32. ATORVASTATIN, PLACEBO

    Disc Medicine

    Atherosclerosis

    approved small molecule active

    1 trial

  33. Acetylsalicylzuur Aurobindo cardio for ST elevation myocardial infarct…

    Disc Medicine

    ST elevation myocardial infarction (STEMI)

    approved small molecule active

    1 trial

  34. Alecensa 150 mg hard capsules

    Disc Medicine

    ALK positive non-small cell lung cancer

    approved small molecule active

    1 trial

  35. Amoxicillin film-coated tablets for non-specific low back pain

    Disc Medicine

    non-specific low back pain

    approved small molecule active

    1 trial

  36. Atropine 1.0% eye drops solution

    Disc Medicine

    Myopia

    approved small molecule active

    1 trial

  37. Bavencio 20 mg/mL concentrate for solution for infusion

    Disc Medicine

    urothelial cancer, Bladder cancer, muscle invasive bladder cancer

    approved small molecule active

    1 trial

  38. CELLULOSE for Angina

    Disc Medicine

    Angina

    approved small molecule active

    1 trial

  39. CELLULOSE for Mimic an acute stress response in humans.

    Disc Medicine

    Mimic an acute stress response in humans.

    approved small molecule active

    1 trial

  40. CO2MO

    Disc Medicine

    Melanoma

    approved small molecule active

    1 trial

  41. COBICISTAT , OLAPARIB

    Disc Medicine

    Cancer

    approved small molecule active

    1 trial

  42. COMBINATIONS

    Disc Medicine

    muscle protein turnover hemodialysis

    approved small molecule active

    1 trial

  43. Ceftriaxon Fresenius Kabi poeder voor oplossi... for Sepsis

    Disc Medicine

    Sepsis

    approved small molecule active

    1 trial

  44. Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie

    Disc Medicine

    Locally advanced head and neck squamous cell carcinoma

    approved small molecule active

    1 trial

  45. Cymbalta hard gastro-resistant capsules for chemotherapy-induced neuropathi…

    Disc Medicine

    chemotherapy-induced neuropathic pain

    approved small molecule active

    1 trial

  46. DIGOXIN

    Disc Medicine

    heart failure

    approved small molecule active

    1 trial

  47. DOTAREM for Breast Cancer

    Disc Medicine

    Breast Cancer

    approved small molecule active

    1 trial

  48. Dexamethasone tablets for Solid tumors

    Disc Medicine

    Solid tumors

    approved small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Disc Medicine have?

308 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.